Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Kurian MV et al. | 2012 | intact cell/cell culture, H9c2 cells (myoblast from embryonal rat myocard) | magnetic field, 50/60 Hz, co-exposure | 1–240 µT |
| Lai H et al. | 2004 | animal, rat/Sprague-Dawley, whole body | magnetic field, 50/60 Hz, co-exposure | 10–500 µT |
| Lazzarini R et al. | 2023 | intact cell/cell culture, MDA-MB-231 cells (breast cancer cell line) and MDA-MB-231 (human breast cell line) | magnetic field, 50/60 Hz | - |
| Lee JS et al. | 2004 | animal, mouse/BALB/c, whole body | magnetic field, 50/60 Hz | 0.1–0.5 mT |
| Li Y et al. | 2014 | animal, zebrafish embryos (<i>Danio rerio</i>), whole body | magnetic field, 50/60 Hz | 30–800 µT |
| Li Y et al. | 2019 | intact cell/cell culture, K562 cells (human erythroleukemic cell line) | magnetic field, 50/60 Hz, also other exposures without EMF | - |
| Lopucki M et al. | 2003 | isolated organ, human placentae (after delivery) | magnetic field, 50/60 Hz | 2 mT |
| Maes A et al. | 2015 | intact cell/cell culture, C3A cells (clonal derivative of Hep G2, a human liver carcinoma cell line) | magnetic field, 50/60 Hz | 5–500 µT |
| Markkanen A et al. | 2008 | intact cell/cell culture, L929 cells (murine fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 100–300 µT |
| Masoudi-Khoram N et al. | 2022 | intact cell/cell culture, MCF-7 and MDA-MB-231 (human breast cancer cell lines) | magnetic field, low frequency, 50/60 Hz | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
